Managing Director, Berkeley Research Group
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
Taking Commercial Speech Seriously
Daniel E. Troy
The Supreme Court’s current approach to commercial speech exemplifies the perils of balancing tests, particularly...
Trademark Anti-Dilution Laws as Cultural Censorship
Jendi B. Reiter
As mass-marketing and advertising have become ever more sophisticated and pervasive, the law's conception of...